http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 20 Jul 2026 16:26:25 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/Inotiv+exits+Chapter+11+with+%24326M+in+debt+reduced/26789996.html <p>Inotiv, Inc. (NASDAQ: NOTV), a contract research organization specializing in nonclinical and analytical drug discovery services, has emerged from Chapter 11 bankruptcy protection after completing its financial restructuring process.</p><p>Through the restructuring, the company reduced its debt by approximately $326 million. Inotiv said its existing stakeholders, who collectively manage more than $60 billion in assets, provided additional capital to support the company going forward.</p><p>"Today marks the completion of our restructuring process and the beginning of a new chapter for Inotiv," said Bob Leasure, President and Chief Executive Officer. "We look forward to a future with significantly less debt and a stronger http://www.streetinsider.com/Corporate+News/Inotiv+exits+Chapter+11+with+%24326M+in+debt+reduced/26789996.html Mon, 20 Jul 2026 16:26:25 -0400 NOTV http://www.streetinsider.com/Press+Releases/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html <p class="bwalignc"> <i>Emerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives</i> </p><p class="bwalignc"> <i>Key senior management continue to lead Inotiv; team remains focused on providing clients with critical research products and services</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection. </p><p> Through the restructuring process, Inotiv has reduced its debt by approximately http://www.streetinsider.com/Press+Releases/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html Mon, 20 Jul 2026 16:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Press+Releases/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html <p class="bwalignc"> <i>Emerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives</i> </p><p class="bwalignc"> <i>Key senior management continue to lead Inotiv; team remains focused on providing clients with critical research products and services</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection. </p><p> Through the restructuring process, Inotiv has reduced its debt by approximately http://www.streetinsider.com/Press+Releases/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html Mon, 20 Jul 2026 16:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Press+Releases/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html <p class="bwalignc"> <i>Emerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives</i> </p><p class="bwalignc"> <i>Key senior management continue to lead Inotiv; team remains focused on providing clients with critical research products and services</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection. </p><p> Through the restructuring process, Inotiv has reduced its debt by approximately http://www.streetinsider.com/Press+Releases/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html Mon, 20 Jul 2026 16:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Press+Releases/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html <p class="bwalignc"> <i>Emerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives</i> </p><p class="bwalignc"> <i>Key senior management continue to lead Inotiv; team remains focused on providing clients with critical research products and services</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection. </p><p> Through the restructuring process, Inotiv has reduced its debt by approximately http://www.streetinsider.com/Press+Releases/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html Mon, 20 Jul 2026 16:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Press+Releases/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html <p class="bwalignc"> <i>Emerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives</i> </p><p class="bwalignc"> <i>Key senior management continue to lead Inotiv; team remains focused on providing clients with critical research products and services</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection. </p><p> Through the restructuring process, Inotiv has reduced its debt by approximately http://www.streetinsider.com/Press+Releases/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html Mon, 20 Jul 2026 16:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Press+Releases/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html <p class="bwalignc"> <i>Emerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives</i> </p><p class="bwalignc"> <i>Key senior management continue to lead Inotiv; team remains focused on providing clients with critical research products and services</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection. </p><p> Through the restructuring process, Inotiv has reduced its debt by approximately http://www.streetinsider.com/Press+Releases/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html Mon, 20 Jul 2026 16:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Press+Releases/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html <p class="bwalignc"> <i>Emerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives</i> </p><p class="bwalignc"> <i>Key senior management continue to lead Inotiv; team remains focused on providing clients with critical research products and services</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection. </p><p> Through the restructuring process, Inotiv has reduced its debt by approximately http://www.streetinsider.com/Press+Releases/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html Mon, 20 Jul 2026 16:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Press+Releases/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html <p class="bwalignc"> <i>Emerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives</i> </p><p class="bwalignc"> <i>Key senior management continue to lead Inotiv; team remains focused on providing clients with critical research products and services</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection. </p><p> Through the restructuring process, Inotiv has reduced its debt by approximately http://www.streetinsider.com/Press+Releases/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html Mon, 20 Jul 2026 16:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Press+Releases/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html <p class="bwalignc"> <i>Emerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives</i> </p><p class="bwalignc"> <i>Key senior management continue to lead Inotiv; team remains focused on providing clients with critical research products and services</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection. </p><p> Through the restructuring process, Inotiv has reduced its debt by approximately http://www.streetinsider.com/Press+Releases/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html Mon, 20 Jul 2026 16:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Business+Wire/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html <p class="bwalignc"> <i>Emerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives</i> </p><p class="bwalignc"> <i>Key senior management continue to lead Inotiv; team remains focused on providing clients with critical research products and services</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection. </p><p> Through the restructuring process, Inotiv has reduced its debt by approximately http://www.streetinsider.com/Business+Wire/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html Mon, 20 Jul 2026 16:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Business+Wire/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html <p class="bwalignc"> <i>Emerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives</i> </p><p class="bwalignc"> <i>Key senior management continue to lead Inotiv; team remains focused on providing clients with critical research products and services</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection. </p><p> Through the restructuring process, Inotiv has reduced its debt by approximately http://www.streetinsider.com/Business+Wire/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html Mon, 20 Jul 2026 16:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Business+Wire/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html <p class="bwalignc"> <i>Emerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives</i> </p><p class="bwalignc"> <i>Key senior management continue to lead Inotiv; team remains focused on providing clients with critical research products and services</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection. </p><p> Through the restructuring process, Inotiv has reduced its debt by approximately http://www.streetinsider.com/Business+Wire/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html Mon, 20 Jul 2026 16:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Business+Wire/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html <p class="bwalignc"> <i>Emerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives</i> </p><p class="bwalignc"> <i>Key senior management continue to lead Inotiv; team remains focused on providing clients with critical research products and services</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection. </p><p> Through the restructuring process, Inotiv has reduced its debt by approximately http://www.streetinsider.com/Business+Wire/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html Mon, 20 Jul 2026 16:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Business+Wire/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html <p class="bwalignc"> <i>Emerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives</i> </p><p class="bwalignc"> <i>Key senior management continue to lead Inotiv; team remains focused on providing clients with critical research products and services</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection. </p><p> Through the restructuring process, Inotiv has reduced its debt by approximately http://www.streetinsider.com/Business+Wire/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html Mon, 20 Jul 2026 16:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Business+Wire/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html <p class="bwalignc"> <i>Emerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives</i> </p><p class="bwalignc"> <i>Key senior management continue to lead Inotiv; team remains focused on providing clients with critical research products and services</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection. </p><p> Through the restructuring process, Inotiv has reduced its debt by approximately http://www.streetinsider.com/Business+Wire/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html Mon, 20 Jul 2026 16:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Business+Wire/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html <p class="bwalignc"> <i>Emerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives</i> </p><p class="bwalignc"> <i>Key senior management continue to lead Inotiv; team remains focused on providing clients with critical research products and services</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection. </p><p> Through the restructuring process, Inotiv has reduced its debt by approximately http://www.streetinsider.com/Business+Wire/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html Mon, 20 Jul 2026 16:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Business+Wire/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html <p class="bwalignc"> <i>Emerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives</i> </p><p class="bwalignc"> <i>Key senior management continue to lead Inotiv; team remains focused on providing clients with critical research products and services</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection. </p><p> Through the restructuring process, Inotiv has reduced its debt by approximately http://www.streetinsider.com/Business+Wire/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html Mon, 20 Jul 2026 16:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Business+Wire/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html <p class="bwalignc"> <i>Emerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives</i> </p><p class="bwalignc"> <i>Key senior management continue to lead Inotiv; team remains focused on providing clients with critical research products and services</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection. </p><p> Through the restructuring process, Inotiv has reduced its debt by approximately http://www.streetinsider.com/Business+Wire/Inotiv+Successfully+Completes+Financial+Restructuring+Process/26789993.html Mon, 20 Jul 2026 16:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Corporate+News/Inotiv%27s+Chapter+11+reorganization+plan+confirmed+by+court/26769645.html <p>Inotiv, Inc. (NASDAQ: NOTV), a contract research organization specializing in nonclinical and analytical drug discovery services, announced that the U.S. Bankruptcy Court for the Southern District of Texas has confirmed its Plan of Reorganization.</p><p>The company said it expects to emerge from Chapter 11 bankruptcy protection shortly, with what it described as a strengthened balance sheet. Inotiv said the restructuring is supported by existing stakeholders who collectively manage more than $60 billion in assets and who provided additional capital to the company.</p><p>"We initiated this process with a clear objective: strengthen our financial foundation and position Inotiv to execute on our long-term http://www.streetinsider.com/Corporate+News/Inotiv%27s+Chapter+11+reorganization+plan+confirmed+by+court/26769645.html Wed, 15 Jul 2026 02:13:29 -0400 NOTV http://www.streetinsider.com/Press+Releases/Inotiv+Announces+Confirmation+of+Plan+of+Reorganization/26769313.html <p class="bwalignc"> <i>Marks critical milestone in financial restructuring process, positioning Inotiv to emerge well-capitalized, with an improved balance sheet and support from key stakeholders</i> </p><p class="bwalignc"> <i>Company is poised to execute on long-term growth objectives</i> </p><p class="bwalignc"> <i>Operations continue as usual, including ongoing study execution and partner engagement</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today that the U.S. Bankruptcy Court for the Southern District of Texas has confirmed the Company’s Plan of Reorganization http://www.streetinsider.com/Press+Releases/Inotiv+Announces+Confirmation+of+Plan+of+Reorganization/26769313.html Tue, 14 Jul 2026 18:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Press+Releases/Inotiv+Announces+Confirmation+of+Plan+of+Reorganization/26769313.html <p class="bwalignc"> <i>Marks critical milestone in financial restructuring process, positioning Inotiv to emerge well-capitalized, with an improved balance sheet and support from key stakeholders</i> </p><p class="bwalignc"> <i>Company is poised to execute on long-term growth objectives</i> </p><p class="bwalignc"> <i>Operations continue as usual, including ongoing study execution and partner engagement</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today that the U.S. Bankruptcy Court for the Southern District of Texas has confirmed the Company’s Plan of Reorganization http://www.streetinsider.com/Press+Releases/Inotiv+Announces+Confirmation+of+Plan+of+Reorganization/26769313.html Tue, 14 Jul 2026 18:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Press+Releases/Inotiv+Announces+Confirmation+of+Plan+of+Reorganization/26769313.html <p class="bwalignc"> <i>Marks critical milestone in financial restructuring process, positioning Inotiv to emerge well-capitalized, with an improved balance sheet and support from key stakeholders</i> </p><p class="bwalignc"> <i>Company is poised to execute on long-term growth objectives</i> </p><p class="bwalignc"> <i>Operations continue as usual, including ongoing study execution and partner engagement</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today that the U.S. Bankruptcy Court for the Southern District of Texas has confirmed the Company’s Plan of Reorganization http://www.streetinsider.com/Press+Releases/Inotiv+Announces+Confirmation+of+Plan+of+Reorganization/26769313.html Tue, 14 Jul 2026 18:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Press+Releases/Inotiv+Announces+Confirmation+of+Plan+of+Reorganization/26769313.html <p class="bwalignc"> <i>Marks critical milestone in financial restructuring process, positioning Inotiv to emerge well-capitalized, with an improved balance sheet and support from key stakeholders</i> </p><p class="bwalignc"> <i>Company is poised to execute on long-term growth objectives</i> </p><p class="bwalignc"> <i>Operations continue as usual, including ongoing study execution and partner engagement</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today that the U.S. Bankruptcy Court for the Southern District of Texas has confirmed the Company’s Plan of Reorganization http://www.streetinsider.com/Press+Releases/Inotiv+Announces+Confirmation+of+Plan+of+Reorganization/26769313.html Tue, 14 Jul 2026 18:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207 http://www.streetinsider.com/Press+Releases/Inotiv+Announces+Confirmation+of+Plan+of+Reorganization/26769313.html <p class="bwalignc"> <i>Marks critical milestone in financial restructuring process, positioning Inotiv to emerge well-capitalized, with an improved balance sheet and support from key stakeholders</i> </p><p class="bwalignc"> <i>Company is poised to execute on long-term growth objectives</i> </p><p class="bwalignc"> <i>Operations continue as usual, including ongoing study execution and partner engagement</i> </p> <p> WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today that the U.S. Bankruptcy Court for the Southern District of Texas has confirmed the Company’s Plan of Reorganization http://www.streetinsider.com/Press+Releases/Inotiv+Announces+Confirmation+of+Plan+of+Reorganization/26769313.html Tue, 14 Jul 2026 18:26:00 -0400 A.05453562 A.10725275 A.24434570 A.30352707 NOTV O.00042666 O.00046809 O.13103550 O.37509207